Product Information
APREPITANT 125 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $115.3368 per EA under NDC 00781232368. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
125 mg/1
Manufacturer
Sandoz Inc.NDC
00781232368
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA090999On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 125 MG CAPSULE has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $115.3368 per EA |
|---|---|
| All-time high | $199.2198 (Sep 10, 2025) |
| All-time low | $115.3368 (Jun 17, 2026) |
| 52-week high | $199.2198 |
| 52-week low | $115.3368 |
| Median price | $172.7479 |
| Average price | $164.9959 |
| Largest weekly change | -11.9% (Jan 21, 2026) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APREPITANT 125 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 125 MG CAPSULE, manufactured by Sandoz Inc., is $115.3368 per EA (NDC 00781232368), effective Jun 24, 2026.
How has the price of APREPITANT 125 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 125 MG CAPSULE has declined 36.7%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for APREPITANT 125 MG CAPSULE?
Since Dec 18, 2024, the NADAC for APREPITANT 125 MG CAPSULE has ranged from a low of $115.3368 (Jun 17, 2026) to a high of $199.2198 (Sep 10, 2025), with a median of $172.7479 per EA.
Are there cheaper alternatives to APREPITANT 125 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as APREPITANT 125 MG CAPSULE, but none are currently priced below it.
Who manufactures APREPITANT 125 MG CAPSULE?
APREPITANT 125 MG CAPSULE (NDC 00781232368) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification